Ascension Ventures has closed its fifth fund at $285m with the backing of 13 health systems.

Ant Group has co-led a $154m round for the medical payments technology provider, which came a year after a China Re-backed series A-plus.

Nationwide Insurance has backed a series E round for Beam that increased the dental insurer’s total funding to $160m.

Ping An and Alphabet-backed health insurer Oscar priced an upsized offering above its range to raise $1.44bn. The offering is part of the broader health space, which has seen many exits in the past years.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The medical examination software provider doubled the size of a round that includes Qualcomm Ventures along with its valuation.

Immuno-oncology therapy developer Lava Therapeutics has filed for a $100m IPO, having been set up in 2016 to exploit Amsterdam University Medical Centers research.

Versant Ventures, which incubated the cell-based immunotherapy developer based on Harvard and Stanford research, has backed a $160m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Returning investor Leaps by Bayer was among the participants in the cell-based immunotherapy developer’s series C round having previously led a $250m round in 2019.